drugset / Trial / NCT07300137

Comparison of Amniotic Membrane Dressing and Aquacel®Ag in Second-degree Burns

NCT07300137 ↗

Enrolling by invitation 100 enrolled Patel Hospital, Pakistan
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the outcome of amniotic membrane dressing versus Aquacel® Ag dressing with respect to the duration of healing in patients with second-degree burns within the local demographic setting. This study aims to address the existing gap in the literature by comparing the efficacy of amniotic membrane dressing and Aquacel® Ag dressing in the management of second-degree burns. Although Aquacel® Ag has been extensively studied for partial-thickness burns, it has not been directly compared with human amniotic membrane dressing, and no randomized controlled trial has yet evaluated these two treatment modalities. The findings of this study are expected to provide healthcare providers with an effective and cost-efficient dressing option for burn patients, particularly in resource-limited countries, while minimizing morbidity.

Timeline

Start
2025-09-20
Primary completion
2026-07-01
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject preserved amniotic membrane dressing Other / unclassified — Topical

Indications

No indication recorded.